Please click here to check who's online and chat with them.

Find Verified Medical Healthcare Suppliers, Manufacturers and Wholesalers

Top Supplier Cities : Seoul   -   Busan  
Oct-04-22
Supplier From South Korea (Republic Of Korea)
Nov-22-16
Supplier From Seongnam-si, South Korea (Republic Of Korea)
Jan-06-21
Supplier From Suwon-si, South Korea (Republic Of Korea)
Mar-04-22
Supplier From Seoul, Seoul, South Korea (Republic Of Korea)
Jan-30-24
Supplier From Gwacheon-si, Gyeonggi-do, South Korea (Republic Of Korea)
 
MastoCheck is a blood test that can easily screen for breast cancer at an early stage. Breast cancer is diagnosed early by substituting the quantitative values of three types of protein biomarkers in the blood, which are closely related to breast cancer, into a unique, patented algorithm.
An innovative and convenient test method that detects early breast cancer with an accuracy of 92% (based on the patent) by using only a very small amount of blood.
Bertis has developed multiple markers that can detect early breast cancer with an accuracy of 92% through identification of multiple proteins that are expressed sensitively in early-stage breast cancer and combination of certain proteins that demonstrated high accuracy
and reproducibility among these combinations.

DEVELOPMENT PROCESS:
- MASTOCHECK was developed by a team led by Professor Dong-Young Noh, a world-renowned authority on breast cancer, of Seoul National University.
- After analyzing approximately 600,000 proteins and selecting 3 markers exhibiting optimal accuracy,
the highest accuracy was obtained by adding Bertis�¢?? own algorithm that enhances accuracy.
- After several years of repeated validation work, a medical device product license was obtained from the MFDS in January 2019. To date (as of September 2023), MASTOCHECK has been introduced to about 400 hospitals and screening institutions nationwide, with priority given to large screening institutions.
2491 Medical Healthcare Suppliers
Short on time? Let Medical Healthcare sellers contact you.
Feb-01-24
Supplier From Gwacheon-si, Gyeonggi-do, South Korea (Republic Of Korea)
 
Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood.

Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood.

High diagnostic accuracy :
Quantitative values of biomarkers are measured and entered in a unique algorithm with applied AI.

Convenience :
No burden of inconvenience caused due to the use of a separate diagnostic device other than blood sampling

Efficiency:
Provides diagnosis opportunities to more people in situations where personnel and devices are limited
Feb-01-24
Supplier From Gwacheon-si, Gyeonggi-do, South Korea (Republic Of Korea)
 
Exo-PASS
Exosomes contain proteins, lipids, nucleic acids, and metabolites, and can be easily enriched from biofluids, providing very valuable information for early detection and monitoring of diseases. The Ministry of Food and Drug Safety requires RNA, lipid and proteomic analyses in its guidelines for the development of exosome therapeutics, and PASS provides these analyses in an all-in-one package.

Exosome RNA Sequencing:

PASS enables rapid and efficient isolation of RNAs and profiling of exosome nucleic acids using qRT-PCR and novel sequencing methods.

Exosome Lipidomics:

We perform high-reliability and high-sensitivity analysis through an ultra-high-performance tool (UPLC, Orbitrap Exploris 480 MS) and lipid analysis experts who have been producing and interpreting analysis data for many years.

Exosome Proteomics:

PASS offers and performs quantification analysis that meets customer needs based on the unique expertise in exosome protein extraction. We provide reliable results through deep profiling of exosome proteome and a specialized data library. Our world-class bioinformatics research team at Bertis reviews and interprets pan-omics data (RNA/Lipid) to support in-depth research.
Feb-01-24
Supplier From Gwacheon-si, Gyeonggi-do, South Korea (Republic Of Korea)
 
PASS is an analysis solution optimized for academia and pharma research. The proprietary solution was derived from proven technology and innovation embedded in Mastocheck, a proteomics-based early cancer diagnostics approved by Ministry of Food and Drug Safety (MFDS).

Bertis developed the PASS solution based on its pan-omics, bioinformatics, and artificial intelligence (AI) technologies. We provide a variety of analyzes for proteomic analysis, biomarker discovery and verification, new drug development, clinical process development, etc.

PASS is a platform for integrative analysis of pan-omics data, based on our proven and reliable bioinformatics analysis capabilities. Our team consists of experienced scientists with an extensive track record of research achievements spanning more than a decade in mass spectrometry-based proteomics.

Bertis possesses the core expertise and proprietary technology for pan-omics (multi-omics) analysis to provide customized solutions in all fields where omics data analysis is applicable.

With PASS, you can leverage Bertis scientific resources and cutting-edge tools to advance your research projects and goals, from the design stage to the interpretation and visualization of bioinformatics analysis results.
Feb-01-24
Supplier From Gwacheon-si, Gyeonggi-do, South Korea (Republic Of Korea)
 
Proteomics-based Early diagnosis using multiple markers provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests.

Early diagnostic solutions
BERTIS has commercialized MASTOCHECK, the worlds first proteomics-based blood test solution for early diagnosis of breast cancer, and clinical trials are being conducted on biomarkers for various cancers. Ultimately, these technologies are being used to continually expand the pipeline to allow dozens of diseases to be diagnosed with a single blood test.
Feb-01-24
Supplier From Gwacheon-si, Gyeonggi-do, South Korea (Republic Of Korea)
 
Biomarker Diseases Diagnosis Blood Tests
Proteomics-based early diagnosis Provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests.

Advantages of proteomics-based early diagnosis:

Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood.

Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood.
Feb-01-24
Supplier From Gwacheon-si, Gyeonggi-do, South Korea (Republic Of Korea)
 
PC-PASS Protein Characterization Analysis
Protein Characterization (Physicochemical property of proteins) structure analysis using mass spectrometry provides results that meet the requirements of the FDA, the MFDS and other regulatory authorities regarding novel therapies or biosimilars. Based on basic amino acid analysis (full sequencing), we perform post-translational modification (PTM) analysis, which is important for protein potency and stability. In this regard, we can perform test methods based on design of experiment (DOE) statistical methodology and deliver documents to be submitted to regulatory authorities.

Protein identification and quantification : Structural analysis of all types of protein therapeutics, including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and enzymes

- Full Length-Amino acids sequencing Peptide identification of each peak through peptide mapping (MS spectrum confirmation, MS/MS spectral analysis with 100% AA matches)
- Improved N- and C-terminal sequencing of proteins

Post-translational modification (PTM) : More reliable results based on design of experiment (DOE) statistical methodology to perform the experiments systematically and analyze data efficiently

- Disulfide bond analysis ID Total possible lankage analysis
- Deamidation identification and quantification
- Phosphorylation identification and quantification , phospho-proteomic analysis
- Other functional modifications

Glycomics : Single protein analysis and research of protein complexes with glycosylation closely related to biological function and toxicity as well as structural stability of proteins

- Glycosylation site determination
- Glycan profiling
- Site-specific glycan identification and quantification
- Glycomics research with glycan enrichment
Dec-26-23
Supplier From Yongin-si, Gyeonggi-do, South Korea (Republic Of Korea)
 
Health and safety products include skin care creams, first aid kits, and Foshan neutralizers
It consists of products that can be used to help further increase worker safety
There are.
Product List

Skin Care Cream
-From sweat, harmful chemicals, oils, acids, alkalis and water in industrial sites
Prevent and care for various skin diseases that may occur (be sure to wear gloves A2)

Emergency First Aid Kit
- Kit for first aid in case of local accidents caused by foshan and acidic chemicals
- Consists of emergency cleansing fluid, bandage, ointment, etc.
May-21-20

Corona Test Kit

$15
MOQ: Not Specified
Supplier From Anyang-Si, Gyeonggi-Do, South Korea (Republic Of Korea)
 
Corona test kit from South Korea. Approval by FDA, CE, FSC.
Kits have been exported to Europe, North America, South America, etc.
Price : EXW KOREA and US$ 15
MOQ : 1,000Kits(can be used for 100,000cases)
Payment Terms : T/T 100% In advance.
Delivery : Contacted DHL.
Production : within a week.
User have to equip RT-PCR. We need to check which one you have.
Feb-13-19
Supplier From South Korea, South Korea (Republic Of Korea)
Aug-12-20
Supplier From Seoul, South Korea (Republic Of Korea)
VERIFIED
Nov-15-21

Nasal Swab For Covid Test

$0.09
MOQ: Not Specified
Supplier From Gunpo-si, Gyeonggi-do, South Korea (Republic Of Korea)
 
*Product : Nasopharyngeal or Oropharyngeal Swab with Breakpoint, Foam Swab, UTM, Saliva Container Kit, *Certification : US FDA, CE, REACH and RoHs, *Origin : South Korea / China, *Price : $0.085~0.195 / unit, *Payment term : 100% TT in advance, *FOB Incheon,
VERIFIED
Mar-10-22
Supplier From Gunpo-si, Gyeonggi-do, South Korea (Republic Of Korea)
 
*Ex works price is around $5.5 per kit all in inclusive 4cents commissions for all the brokers.
*Made in Korea, *Celltrion is a very well-known large corporation in Korea, and is one of the few companies that has been approved by the US FDA. *Detailed consultation is possible when submitting LOI.
VERIFIED
Jul-09-22

Eskimo Pro

$2.80K
MOQ: Not Specified
Supplier From Yangju-Si, Gyeonggi-Do, South Korea (Republic Of Korea)
 
ESKIMO COOLING SYSTEM is designed for multi-purpose in dermatology and orthopedics.
Its performance covers a skin cooling from diverse laser treatment in dermatology to pain relief in orthopedics, by emitting 40'C cold air which generated in system.
In dermatology treatment, ESKIMO uses in parallel with heat generated laser systems that includes Diode lasers, Q Switched ND-Yag laser, IPL system, Co2 laser, Ruby lasers etc, and which leads to fast renewal of skin and reduce a downtime.
In orthopedics, it helps to reduce inflammations inside.


KEY FEATURES

â?  2 BLADED SUCTION MOTOR MAKES LESS NOISE WITH MORE AIRFLOWS
â?  EMITS ONLY DRIED AIR AND PROVIDES NO SIDE EFFECTED TREATMENT
â?  EASY USE WITH CYNOSURE AND CANDELA LASER SYSTEM
â?  NO ICING PROBLEM IN EVAPORATOR
â?  40,000 HOURS OF LONG LIFE SPAN OF SUCTION MOTOR
â?  2 Year warranty
â?  ALL DIGITAL AND TOUCH SCREEN
â?  CAN SET SUBTLE CALIBRATION EVEN BETEEN EACH LEVELS

SPECIFICATIONS
* Cooling Temperature : From 0�°C to -35�°C (Max. -40�°C)
* Water outlet timing alarm system
* De-frost function adopted
* Full colored touch screen 7 inch
* Blow Motor : Max 26,000 RPM/Min
* Power consumption: 2.4KW(max)
* Silence technology : Appx. 65db
* Air Flow: 1,350L/min
Mar-29-20
Supplier From Hanam, Gyung Gi, South Korea (Republic Of Korea)
Sep-14-21
Supplier From Daegu, Gyungsangbuk-do, South Korea (Republic Of Korea)
2491 Medical Healthcare Suppliers
Short on time? Let Medical Healthcare sellers contact you.